diabetes
-
November 17, 2020
A cohort for type 2 diabetes studies
A study group of more than 600,000 patients with type 2 diabetes, identified from electronic medical records in the PCORnet national research network, could be valuable for assessing the safety of type 2 diabetes drugs. -
November 13, 2020
VUMC employee attends honor walk for her brother, becomes passionate organ donation advocate
Her brother Taylor's death was heartbreaking, but Anna Lorenz is determined to inspire others with his example -
November 3, 2020
New treatment for a rare obesity
Diabetes drugs known as GLP-1 receptor agonists, such as exenatide (Byetta), are a promising and safe treatment for a rare form of obesity. -
October 5, 2020
Clue to diabetic kidney disease
Vanderbilt researchers have identified a signaling pathway that promotes kidney fibrosis in patients with diabetes — and that could be targeted with an existing approved medication. -
July 28, 2020
Study challenges idea that lower BMI shields smokers from fat-associated health risks
While some smokers might rationalize continuing to smoke because of the lower weight often associated with the habit, Vanderbilt University Medical Center investigators have determined that even with a lower body mass index (BMI), smokers have a higher risk of depositing fat in and around organs and tissues compared to those who never smoked. -
July 9, 2020
Keeping beta cells “fit”
Vanderbilt cell biologists are defining the factors that help beta cells in the pancreas stay healthy, secrete insulin and prevent diabetes initiation and progression. -
June 11, 2020
Staff Nurses of the Year named
Rosamund Gabrielson Staff Nurse of the Year recipients were announced representing the four entities of VUMC